José M López-Novoa Selected Research

Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left)

7/2015	Plasma Cardiotrophin-1 as a Marker of Hypertension and Diabetes-Induced Target Organ Damage and Cardiovascular Risk.
12/2010	Increased plasma soluble endoglin levels as an indicator of cardiovascular alterations in hypertensive and diabetic patients.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

José M López-Novoa Research Topics

Disease

24	Fibrosis (Cirrhosis) 01/2019 - 11/2002
12	Hypertension (High Blood Pressure) 01/2020 - 01/2005
7	Neoplasms (Cancer) 01/2020 - 09/2007
7	Necrosis 01/2018 - 08/2006
6	Inflammation (Inflammations) 10/2018 - 08/2006
5	Acute Kidney Injury (Acute Renal Failure) 01/2020 - 06/2004
4	Reperfusion Injury 01/2020 - 07/2002
4	Ischemia 10/2018 - 07/2002
3	Ureteral Obstruction 01/2018 - 11/2002
3	Chronic Renal Insufficiency 01/2018 - 06/2010
3	Infections 01/2016 - 04/2006
3	Wounds and Injuries (Trauma) 01/2014 - 05/2010
2	Pre-Eclampsia (Preeclampsia) 12/2020 - 03/2007
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2020 - 10/2013
2	Colitis 12/2019 - 01/2018
2	Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left) 07/2015 - 12/2010
2	Chronic Kidney Failure (Chronic Renal Failure) 01/2014 - 03/2010
2	Kidney Diseases (Kidney Disease) 01/2012 - 04/2006
2	Proteinuria 01/2012 - 01/2005
2	Hereditary Hemorrhagic Telangiectasia 10/2010 - 03/2006
2	Hypoxia (Hypoxemia) 06/2008 - 07/2002
1	Neoplasm Metastasis (Metastasis) 01/2020
1	Peripheral Vascular Diseases (Peripheral Vascular Disease) 07/2015
1	Hyperglycemia 01/2014
1	Cicatrix (Scar) 01/2013
1	Hypertrophy 01/2012
1	Albuminuria 01/2012

Drug/Important Bio-Agent (IBA)

15	EndoglinIBA 12/2020 - 11/2002
9	Proteins (Proteins, Gene)FDA Link 01/2018 - 01/2005
7	Gentamicins (Gentamicin)FDA LinkGeneric 01/2020 - 12/2002
7	CytokinesIBA 01/2016 - 04/2010
7	Transforming Growth Factor beta1 (TGF beta 1)IBA 11/2008 - 07/2002
6	Cisplatin (Platino)FDA LinkGeneric 01/2020 - 07/2011
6	CollagenIBA 01/2018 - 11/2002
5	Pharmaceutical PreparationsIBA 01/2018 - 11/2010
4	AminoglycosidesIBA 01/2016 - 04/2006
4	Anti-Bacterial Agents (Antibiotics)IBA 01/2016 - 04/2006
4	Transforming Growth Factor beta (TGF-beta)IBA 12/2015 - 03/2010
4	Angiotensin IIIBA 10/2015 - 07/2002
3	Biomarkers (Surrogate Marker)IBA 01/2020 - 07/2015
3	Extracellular Matrix ProteinsIBA 01/2018 - 12/2013
3	ras ProteinsIBA 10/2016 - 01/2009
3	Activin Receptors (Activin Receptor)IBA 01/2016 - 02/2014
3	CreatinineIBA 07/2015 - 08/2006
3	Fibronectins (Fibronectin)IBA 06/2014 - 11/2002
2	Drinking WaterIBA 12/2019 - 01/2018
2	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 10/2018 - 01/2018
2	Messenger RNA (mRNA)IBA 01/2018 - 11/2002
2	Erythropoietin FDA Link 01/2018 - 09/2007
2	AntioxidantsIBA 09/2017 - 04/2006
2	Protein Isoforms (Isoforms)IBA 10/2016 - 12/2009
2	Bone Morphogenetic Proteins (Bone Morphogenetic Protein)IBA 01/2016 - 12/2015
2	NG-Nitroarginine Methyl Ester (L-NAME)IBA 10/2015 - 01/2014
2	ChemokinesIBA 07/2015 - 04/2010
2	Transforming Growth Factors (Transforming Growth Factor)IBA 12/2013 - 10/2010
2	Indicators and Reagents (Reagents)IBA 05/2012 - 12/2010
2	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2009 - 01/2005
2	Antihypertensive Agents (Antihypertensives)IBA 01/2009 - 07/2006
2	Phosphotransferases (Kinase)IBA 01/2008 - 01/2006
2	Collagen Type I (Type I Collagen)IBA 12/2007 - 01/2005
2	Collagen Type IV (Type IV Collagen)IBA 01/2005 - 11/2002
1	Membrane Glycoproteins (Membrane Glycoprotein)IBA 01/2020
1	Dextran SulfateIBA 12/2019
1	cardiotrophin 1IBA 01/2019
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 10/2018
1	Superoxides (Superoxide)IBA 10/2018
1	OSM-LIF ReceptorsIBA 10/2018
1	Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA 10/2018
1	Dextrans (Dextran)FDA Link 01/2018
1	Acetylcysteine (Siran)FDA LinkGeneric 01/2018
1	SodiumIBA 01/2018
1	Tumor Biomarkers (Tumor Markers)IBA 01/2018
1	Caspase 3 (Caspase-3)IBA 01/2018
1	QuercetinIBA 09/2017
1	Interleukin-6 (Interleukin 6)IBA 01/2016
1	LigandsIBA 01/2016
1	MicroRNAs (MicroRNA)IBA 12/2015
1	AntibodiesIBA 12/2015
1	Kallikreins (Kallikrein)IBA 10/2015
1	Peptide Hydrolases (Proteases)FDA Link 10/2015
1	Desoxycorticosterone Acetate (DOCA)FDA Link 10/2015
1	Serine Proteases (Serine Protease)IBA 10/2015
1	SaltsIBA 10/2015
1	AlbuminsIBA 07/2015
1	Connective Tissue Growth FactorIBA 06/2014
1	LA 803IBA 01/2014
1	Lipocalin-2IBA 01/2014
1	Keratin-17 (Keratin 17)IBA 01/2014
1	OsteoprotegerinIBA 05/2012
1	MTOR InhibitorsIBA 01/2012
1	TOR Serine-Threonine KinasesIBA 01/2012
1	Everolimus FDA Link 01/2012

Therapy/Procedure

3	Drug Therapy (Chemotherapy) 11/2011 - 07/2006
3	Ligation 05/2005 - 11/2002
2	Organ Transplantation 10/2018 - 01/2012
2	Transplantation 10/2018 - 08/2009
2	Therapeutics 09/2015 - 03/2010
1	Kidney Transplantation 10/2018
1	Renal Replacement Therapy (Therapies, Renal Replacement) 01/2014
1	Operative Surgical Procedures 01/2012